ArticleBlood advances2017

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies.

Shu-Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.